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ABSTRACT 
Objective: The objective of this research was to formulate and evaluate the different grades of rizatriptan benzoate loaded polysaccharide based 
microspheres for the nasal drug delivery system. 
Methods: The polysaccharide was extracted from the seed of Trigonella foenum-graecum and microspheres were prepared by emulsification, 
followed by crosslinking using epichlorohydrin. A 32 full factorial design was employed in formulating the microspheres with polymer 
concentration (X1), and stirring rate (X2) as independent variables and particle size (Y1) and entrapment efficiency (Y2
Results: The microspheres were discrete and free-flowing. The mean particle size (Y
) were dependent variables. 
1) of microspheres ranged from 40.82+12 µm to 62.48+0.41 
µm and the encapsulation efficiency (Y2) was found to be increased from 60.7+0.2% to 79.22+0.2% as the drug polysaccharide ratio increased. A 32 
full factorial design confirmed that the X1 and X2 both effect on particle size whereas X1 
Conclusion: The result obtained in this research work indicate a promising potential of control release rizatriptan benzoate loaded microspheres 
whereas the Trigonella foenum-graecum polysaccharide used as rate controlling polymer for the effective treatment of migraine patients. 
alone effect on entrapment efficiency. SEM revealed the 
smooth spherical surface of microspheres whereas kinetic model revealed that drug release followed the case II transport. FTIR indicated good 
compatibility of the excipients with rizatriptan benzoate. Stability studies were carried out for formulation F7 at 4°C ambient, 25+2°C/60+5%, 
40+2°C/75+5% relative humidity revealed that the physical drug appearance, entrapment efficiency were within the permissible limits. 
Keywords: Rizatriptan benzoate, Polysaccharide, Microspheres, Nasal drug delivery. 




In a novel drug delivery system, various route of administration may 
be used to achieve the controlled and targeted drug delivery [1]. A 
nasal cavity, as a site of drug delivery, have many advantages such as 
avoid first-pass metabolism, applicability for long-term treatment and 
because of the large surface area for absorption it may provide ease of 
administration. In a novel drug delivery system, microspheres are 
used to improve the bioavailability and stability of a drug. Intranasal 
drug administration is receiving increased attention as a delivery 
method for bypassing the blood-brain barrier (BBB) and rapidly 
targeting therapeutics to the central nervous system (CNS) [2]. There 
are two classes of nasal delivered therapeutics are in the market. The 
first one comprises with low molecular weight and hydrophobic drugs 
mostly useful in the treatment of the nasal mucosa and sinus. Whereas 
the second class of drugs having poor absorption properties, 
instability in a gastrointestinal tract (GIT) and have a sufficient nasal 
absorption to display systemic effects [3]. Single emulsion technique is 
a well-established process for microspheres preparation. The 
microparticulate carriers of natural polysaccharides i.e., those of 
proteins and carbohydrates are prepared by a single emulsion 
technique. The natural polymers are dissolved or dispersed in aqueous 
medium followed by dispersion in a non-aqueous medium like oil. In 
the next step, the cross-linking of the dispersed globule is carried out. 
The cross-linking can be achieved either by heat or by using the 
chemical crosslinkers [4]. 
Rizatriptan benzoate is a selective serotonin (5-hydroxytryptamine; 5-
HT) type 1B and 1D receptor agonist (“triptan”) commonly used for the 
treatment of a migraine and completely absorbed from GIT, but absolute 
bioavailability (as conventional tablet) is 45%, indicating the first-pass 
metabolism, which is due to the metabolism of the drug by monoamine 
oxidase A isoenzyme (MAO-A) to an inactive indole acetic acid 
metabolite. Rizatriptan benzoate has also relatively short elimination 
half-life (about 3 h) and the prolonged drug release is needed [5, 6]. 
The aim of this research was, to formulate and evaluated rizatriptan 
benzoate loaded polysaccharide based microspheres for the delivery 
via the nasal route with aim to avoid hepatic first-pass metabolism, 
and enhance residence time. The natural polysaccharide was 
extracted from the seeds of Trigonella foenum-graecum L. (Fenugreek 
seeds, Family: Fabaceae) as mucoadhesive excipient [7]. In traditional 
Chinese medicine, it is also used for kidney problems and conditions 
affecting the male reproductive tract. The recent researches have 
proved it beneficial for atherosclerosis, constipation, diabetes, high 
cholesterol and hypertriglyceridemia [8]. 
MATERIALS AND METHODS 
Materials 
Rizatriptan benzoate was obtained as a generous gift from Cipla 
(Raighar, India). Castor oil, epichlorohydrin, Isopropyl alcohol and 
acetone were purchased from the CDH, (New Delhi, India). All other 
reagents used were of analytical grade. 
Extraction of fenugreek polysaccharide 
Extraction of polysaccharide was done using a reported method [9, 
10] with minored modification. The plant materials of Trigonella 
foenum-graecum (fenugreek seeds, NHCP/NBPGR/2014-16) were 
collected from the local market in Meerut (India), and were washed 
with water to remove dirt, dried and crushed them to convert into 
powdered form. The powder was soaked in water for 5-6 h, boiled 
for 30 min. and allowed to stand for 1hr so that all the mucilage was 
released into the water. Then the materials were squeezed from 
muslin bag to remove the marc from the solution. After that 1500 ml 
of acetone was added to the filtrate to precipitate the mucilage. The 
mucilage was separated, dried in an oven at a temperature less than 
50 °C, and the dried powder was passed through a sieve no. 80 and 
retained on sieve no. 100. It was stored in desiccators. 
Preparation of microspheres by emulsion technique 
Microspheres of Trigonella foenum-graecum polysaccharides 
were prepared using an emulsification technique. Aqueous 
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solutions containing different drug and polysaccharide ratios 
(1:1 to 1:3) were prepared by dissolving required amount of 
rizatriptan benzoate and polysaccharide in distilled water. The 
final volume was adjusted in such a way such a way that the 
concentration of the polysaccharide in the final solution was 2% 
w/v. The mixture was kept for 4 h under magnetic stirring at 100 
rpm (round per minute) for completed hydration of 
polysaccharide. An aqueous phase was emulsified into castor oil 
using span 80 (1% v/v) as an emulsifying agent. The phase: 
volume ratio of the oil and aqueous phase was maintained at 
10:1. The emulsion was homogenized for 5 min. with the 
addition of 0.2 ml H 2SO 4  using high speed a mechanical stirrer 
(Yamato, LT400, Tokyo, Japan) at different rotation rate (2000 to 
3000 rpm). Epichlorohydrin (4% v/v) was added for covalent 
crosslinking of droplets. Stirring was continued for 18 h at 40ο
Experimental design 
C. 
The formed microspheres were separated by sedimentation and 
centrifugation at 1500 rpm for 5 min. Microspheres were 
washed thrice using isopropyl alcohol [11]. 
The design of the experiment is an approach for effectively and efficient 
exploring the cause and effect relationship between process variables 
and output. A 2-factor 3-level factorial central composite experimental 
design technique was employed to investigate the variables. This 
technique was applied to quantify the influence of operating parameters 
on the particle size and entrapment efficiency of microspheres. The 
dependent variables were polymer concentration and stirring rate. The 
factorial design parameters and experimental condition are shown in 
table 1. Various batches of rizatriptan benzoate loaded microspheres 
were prepared based on the 32 factorial designs. The independent 
variables were polymer concentration 1 to 3% (X1) and stirring rate 
2000 to 3000 rpm (X2
 
) and their levels were shown in table 1. 
Table 1: Factorial design parameters and experimental condition 
S. No. Coded value Actual value 
Drug-polysaccharide ratio (X1 Stirring rate in rpm (X) 2) 
1 -1 1:1 2000 
2 0 1:2 2500 
3 +1 1:3 3000 
 
Optimization data analysis and model validation 
A nonlinear quadratic polynomial model was generated to more 
precisely evaluated effect of independent variables on dependent 
variables using Design Expert v10 software (Stat-Ease, Inc. 
Minneapolis, MN). 
Yi = β0+β1X1+β2X2+β3X3+β3X1X2+β4X1 2+β5X2 2
Where Y
………………… (1) 
i  is the level of response variable, β i (β1 , β2 , β3 , β4 and β5) is 
the regression coefficient; X1, X2 stands for the main effect; X1X2 is 
the interactions between the main effects, and X1, X2 are quadratic 
terms of the independent variables that are used to simulate the 
curvature of the designed sample space. The X1 and X2
The polynomial equation was used to draw conclusions after 
considering the magnitude of coefficients, and the mathematical sign it 
carries, i.e., positive or negative. A positive sign signifies a 
synergistic effect, whereas a negative sign stands for an 
antagonistic effect. In the model analysis, the responses: the 
particle size of the microsphere and entrapment efficiency of all 
model formulations were treated by Design Expert® software. The 
best fitting mathematical model was selected based on the 
comparisons of several statistical parameters including the 
coefficient of variation (CV), the multiple correlation coefficient 
(R
 were termed 
as codes for the concentration of polysaccharide and stirring rate. 
2), adjusted multiple correlation coefficient (adjusted R2
Characterization of microspheres 
), and 
the predicted residual sum of square (PRESS), provided by Design 
Expert® software. Level of significance was considered at p<0.05. 
Three-dimensional response surface plots resulting from 
equations were obtained by the Design Expert® software [12]. 
Production Yield 
The production yield of microspheres of various batches were 
calculated using the weight of final product after drying with respect 
to the initial total weight of the drug and polymer used for the 
preparation of microspheres [13].  
Yield (%) =
Weight of microspheres
Total expected weight of drug and polymer
× 100 … … . (2) 
Particle size analysis 
The geometric particle size of microspheres was measured using a 
phase contrast microscope (Radical Instruments, India). Suspension 
of microspheres was prepared in paraffin oil. Two or three drops of 
the suspension were transferred onto a glass slide and covered with 
a coverslip. The geometrical diameter of 300 microspheres of each 
batch was separately measured, and the average diameter was 
calculated [14].  
Entrapment efficiency 
For the estimation of encapsulation efficiency and drug content, 
accurately weighed a sample of microspheres (20 mg) was dispersed 
in 20 ml phosphate buffer (pH 6.8). The dispersion was sonicated for 
30 min and kept overnight for the complete erosion of microspheres. 
Then the sample was centrifuged (Remi), filtered and analyzed using 
a UV-visible spectrometer (Shimadzu 1700, Japan) at 225 nm. After 
that encapsulation efficiency and drug content of microsphere were 
calculated by the following equation (3). 
Encapsulation efficiency (%)  
=
Actual amount of drug
Theoretical amount of drug
× 100 … . . (3) 
Fourier transforms infrared spectroscopy (FTIR) studies 
To determine any possible changes in the chemical nature of the 
drug during the preparation of microspheres, FTIR spectra of drug, 
polysaccharide, and the microspheres were recorded by using the 
FTIR spectrophotometer (Shimadzu, Kyoto, Japan) following the 
potassium bromide disc method. 
Scanning electron microscopy (SEM) 
The surface morphology of the microspheres was studied using SEM 
(Leo, 435 VP, Milpitas, CA). Microspheres were placed on an 
aluminum stub with double-sided adhesive tape and were subjected 
to gold sputtering before SEM analysis. 
In vitro drug release 
The in vitro release of the drug from the microspheres was studied 
using the modified dissolution method [15]. An accurately 
weighed amount of microspheres equivalent to 10 mg of drug was 
suspended into 10 ml of phosphate buffer (pH 6.8) in a beaker 
containing 0.1% v/v of Tween 80. The microspheres were packed 
into a small pouch of filter paper, which was kept immersed in the 
dissolution medium.  
The medium was maintained at 37+1οC and continuously stirred at 
50 rpm using a magnetic stirrer. Samples (200 ml) were withdrawn 
at the time interval of 5 min., diluted, filtered and centrifuged at 
4000 rpm for 15 min. The supernatant was collected and estimated 
for the drug content using UV spectrophotometer at 225 nm. 
Quantitative estimation of released drug was done using a 
calibration curve of the drug in a phosphate buffer of pH 6.8 in the 
concentration range of 1–10 µg/ml. 
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Drug release kinetics 
To study the release kinetics of rizatriptan benzoate from Trigonella 
foenum-graecum microspheres, dissolution data were fit according 
to Zero-order, First-order, Higuchi, and Korsmeyer–Peppas 
equations. Value of kinetic rate constant (k), mucoadhesive 
microspheres of Trigonella foenum-graecum correlation coefficient 
(r2) and release exponent (n) were calculated to find out the best fit 
model. To investigate the drug release mechanism, the release data 
were fitted to model representation: Zero order (see equation 4) as 
cumulative amount of drug released vs. time, First order (see 
equation 5) as log cumulative percentage of drug remaining vs. time 
and Higuchi's model (see equation 6) as cumulative percentage of 
drug released vs. square root of time [12]. 
Zero-order 
C = K0t …….. (4) 
Where K0 is the zero-order rate constant expressed in units of 
concentration/time and t is the time in minutes. A graph of 
concentration vs. time would yield a straight line with a slope equal 
to K0 and intercept the origin of the axes. 
First order 
Log C = Log C0 − K𝑡𝑡/2.303 …….. (5) 
Where C0 is the initial concentration of d the rug, K is the first order 
constant and t is the time. 
Higuchi model 
 Qt = Kt1/2 ……….. (6) 
Where Qt
Korsmeyer-peppas model 
 is the amount of drug release in time t, K is the kinetic 
constant and t is the time in minutes. 
A more stringent test was used to distinguish between the 
mechanisms of drug release. The release data were fitted to the 
Peppas exponential model as a cumulative log percentage of drug 
released vs. log time (equation 7). The release exponent n and K 
value were calculated through the slope of the straight line. 
Mt/M∞ = Ktn
Where M
 ………. (7) 
t represents an amount of the released drug at time t, M∞ 
Stability studies 
is the 
total amount of drug released after an infinite time, K is the diffusion 
characteristic of drug polysaccharide system constant and n is an 
exponent that characterizes the mechanism of drug release. The value of 
n indicates the drug release mechanism from the delivery system. If the 
exponent n=0.43 then the drug release mechanism is Fickian diffusion, if 
0.43<n<0.85 then it is non-Fickian or anomalous diffusion, if n=0.85 
mechanism is non-Fickian case II diffusion [16, 17]. 
Stability study was carried out for rizatriptan benzoate loaded 
microspheres as per ICH guidelines. The best batch of microspheres was 
sealed in an ambered coloured bottle and stored at 25+2°C/60+5%, 
40+2°C/75+5% relative humidity (RH) for 90 d. The sample was 
evaluated for physical appearance and entrapment efficiency [22]. 
RESULTS AND DISCUSSION 
Formulation of microspheres 
Nine formulations of rizatriptan benzoate loaded mucoadhesive 
microspheres were prepared by emulsion technique using factorial 
design, in which the independent variables of drug polysaccharide 
ratio 1 to 3% (X1) and stirring rate (X2) 2000 to 3000 rpm and 
particle size (Y1) and % entrapment efficiency (Y2
 
) were taken a 
response parameters as the dependent variables as shown in table 2.
Table 2: Formulation of microspheres using 32
Batch code 













F -1 1 -1 40.82+0.12 60.70+0.20 
F -1 2 0 55.82+0.50 62.60+0.10 
F -1 3 +1 62.48+0.41 65.07+1.30 
F 0 4 -1 49.15+1.02 67.46+0.50 
F 0 5 0 49.15+0.70 68.66+0.41 
F 0 6 +1 49.98+1.20 69.64+0.8 
F +1 7 -1 60.81+0.50 70.84+1.2 
F +1 8 0 57.48+0.80 76.83+0.3 
F +1 9 +1 46.65+0.20 79.22+0.2 
a
 
Optimization data analysis and model-validation 
Fitting of data to the model 
mean+SD, (n= 3),n= number of observation, F = formulation code of microspheres 
The two factors with lower, middle and upper design points in 
coded and encoded values are shown in table 1. The ranges of 
responses Y1 and Y2 were 40.82+0.12-62.48+0.41μm and 
60.70+0.2-79.22+0.2%, respectively. Response observed for all the 
prepared batches were fitted to various models using Design-
Expert® software. It was observed that the best-fitted models 
were F1 for particle size and linear for entrapment efficiency. The 
values of R2, adjusted R2, predicted R2
The result of ANOVA in table 4 for the dependent variables 
demonstrates that the model was significant for both the 
response variables. It was observed that independent variables 
drug polysaccharide ratio (X
, SD and % CV are given in 
table 3. 
1 ) and stirring rate (X 2 ) had a 




Table 3: Summary of results of regression analysis for response Y1 and Y
Models 
2 
R Adjusted R2 Predicted R2 SD 2 %CV 
Response (Y1
F1 model 
) 0.8368 0.7388 0.6801 3.63 6.92 
Response (Y2
Linear model 
) 0.9567 0.9422 0.8884 1.47 2.12 
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Table 4: Results of analysis of variance for a measured response 


















































Particle size (Y1) = 11.94+18.88X1+19.29X2-8.95X1X2 ………. (8) 
Entrapment efficiency (Y2) = 51.18+6.42X1+2.48X2 …………..……… 
From the above equation 8 it was confirmed that the major factor 
which is influencing the particle size of the film is stirring rate (X
(9) 
2). 
The interaction factor between both the independent variables is 
very less. The concentration of Trigonella foenum-graecum (X1) also 
has an effect on particle size of Trigonella foenum-graecum 
microsphere. In case of entrapment efficiency, the concentration of 
Trigonella foenum-graecum (X1
Polynomial quadratic models were generated for each response 
parameter, and the regression coefficients for each term regression 
model were summarized in table 5 together with r
) also has an effect on entrapment 
efficiency of microsphere because the higher the amount of 
polysaccharide, the more will be entrapment efficiency because of 
the more availability of polysaccharide to encapsulate the drug. 
2, F values (with p-
values) of the regression model. In the present study, the model was 
significant in all the cases because for all the dependent variables, 
the p value for the generated model was less than 0.05. Effects of 
formulation variables on different dependent variables were 
assessed by this generated regression coefficient and r2
  
 values. The 
high values of correlation coefficients for all the response variables 
indicate a good fit (i.e., good agreement between the dependent and 
independent variables). 
Table 5: Regression coefficient and r2
Regression coefficient 
values for Trigonellafoenum-graecum microspheres containing rizatriptan benzoate 
β β0 β1 β2  3 
r
F-values for the model (p-value) 
2 Independent variables  X X1 X2 1X2 
Dependent variables   
Particle size 11.94 18.88 19.29 -8.95  0.8368 8.54 (0.0206) 
Entrapment efficiency 51.18 6.42 2.48 0 0.9567 66.23 (<0.0001) 
 
Response surface plot analysis 
Three-dimensional response surface plots generated by the Design 
Expert® software are presented (in fig. 1 and 2) for the studied 
responses, i.e., particle size and entrapment efficiency. The (fig. 1) depicts 
response surface plot of drug polysaccharide ratio (X1) and stirring rate 
(X2) on particle size, which indicate that X1 and X2 show linear effect i.e., 
when increased polysaccharide concentration and stirring rate from 
2000 to 3000 the value of particle size was decreased. The (fig. 2) 
represent response surface plot of the effect of drug polysaccharide ratio 
(X1) and stirring rate (X2
Optimization and validation 
) on entrapment efficiency which indicate a 
linear effect. This explains that the higher the amount of polysaccharide, 
the more will be entrapment efficiency because of the more availability 
of polysaccharide to encapsulate the drug. 
The result in table 6 illustrates the comparison between the 
observed values of both the response Y 1 and Y2 
 
for all the 
batches were presented. It can be seen that in all cases there was 
a reasonable agreement between the experimental values. The 
equations describe the influence of the selected independent 
variables on the responses under study adequately. This 
indicates that the optimization technique was appropriated for 
optimizing the rizatriptan benzoate loaded Trigonella foenum-
graecum microsphere. The low magnitudes of error in the 
present investigation prove the high prognostic ability of the 
optimization technique by factorial design. 
 
Fig. 1: Response surface plots for the X1 and X2 on particle size (Y1), where X1 = drug polysaccharide ratio, X2
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Fig. 2: Response surface plots for the X1 and X2 on entrapment efficiency (Y2), where X1= drug polysaccharide ratio and X2
 
 = stirring rate 
Table 6: The predicted and observed response variables of the rizatriptan benzoate loaded microspheres 
Formulation code Actual and predicted values for 
Particle size (Y1 Entrapment efficiency (Y) 2) 
Actual value Predicted value Residual Actual value Predicted value Residual 
F1 40.82 41.16 -0.34 60.70 60.08 0.62 
F2 55.82 51.50 4.32 62.60 62.56 0.04 
F3 62.48 61.84 0.64 65.07 65.04 0.03 
F4 49.15 51.09 -1.94 67.46 66.50 0.96 
F5 49.15 52.48 -3.33 68.66 68.98 -0.32 
F6 49.98 53.87 -3.89 69.64 71.46 -1.82 
F7 60.81 61.02 -0.21 70.84 72.92 -2.08 
F8 57.48 53.46 4.02 76.83 75.40 1.43 
F9 46.65 45.90 0.75 79.22 77.88 1.34 
F= formulation code of microspheres 
 
Characterization of microspheres 
Percentage yield  
The percentage yield of production was found in the range 
64.5+0.2% to77.60+0.6% (table 7). These respectively low values 
could be attributed mainly to the loss of fines particles during the 
washing of microspheres with Isopropyl alcohol. 
Particle size 
The mean particle size of microspheres ranged from 40.82+10 µm to 
62.48+6.56 µm (table 7), indicating a narrow size distribution (fig. 
1). Such a particle size distributions were considered favorable for 
intranasal administration. The particle size of microsphere was to 
increase with an increase in the drug polysaccharide ratio. The 
formation of larger droplets during emulsification due to the higher 
viscosity of polysaccharide solution at higher concentration. 
Increase stirring rate also contributed to decreasing the particle size 
but not much significantly and this may be due to the narrower 
range being selected to focus this parameter [20]. 
Encapsulation efficiency result 
The percentage encapsulation efficiency was found to increase as the 
drug polysaccharide ratio increased (table 7). It was 60.7+0.2% in a 
batch F1 (1:1 drug polysaccharide ratio) and increased subsequently, 
to 79.22+0.22% in a batch F9 (1:3 drug polysaccharide ratio). The 
reason behind the increased value of percent encapsulation efficiency 
is the more availability of Trigonella foenum-graecum polysaccharide 
as a carrier for the encapsulation of drug. At high concentration of 
polysaccharide, highly viscous aqueous droplets are formed during 
emulsification, which makes a complex network of polysaccharide and 
prevents the migration of drug into surrounding media [21]. In a batch 
F1 with drug polysaccharide ratio 1:1, drug loading was less because 
most of the drug remained unentrapped due to an insufficient amount 
of carrier polysaccharide. 
 
Table 7: Mean value of percentage yield, particle size and entrapment efficiency of microspheres 
 Batch code Percentage yielda Particle size(%+SD) a Entrapment efficiency(µm+SD) a (%+SD) 
F1 64.5+0.2 40.82+0.12 60.70+0.20 
F2 70.4+0.5 55.82+0.50 62.60+0.10 
F3 76.2+0.1 62.48+0.41 65.07+1.30 
F4 74.5+0.2 49.15+1.02 67.46+0.50 
F5 69.7+1.3 49.15+0.70 68.66+0.41 
F6 72.3+0.1 49.98+1.20 69.64+0.8 
F7 77.6+0.6 60.81+0.50 70.84+1.2 
F8 71.4+1.4 57.48+0.80 76.83+0.3 
F9 73.1+0.2 46.65+0.20 79.22+0.2 
a
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Interpretation of FTIR spectrum of Trigonella foenum-graecum 
polysaccharide (fig. 3(a)) was:--OH stretch (3656.78),-C-H (3150.50),-
C=C (2313.46),-C-H bend (1636.49),-C-H rock (1617.20),-CH bend out 
of plane (1029.45) and FTIR spectrum of rizatriptan benzoate (fig. 
3(b)) was-NH stretching (3446),-CH3 stretching (2947),-CH2 
stretching (2893),-C=C stretching (1608), -C=N stretching (1506),-NH 
bending (1570),-CH2 bending (1458),-CH3
The spectrum of physical mixture indicates that there was no evidence of 
any possible interaction between the drug and the polysaccharide and 
characteristic peaks of the pure drug were found present in the 
spectrum of mixture (fig. 3 (c)), which confirmed the absence of 
interaction between a drug and the polysaccharide [10, 18-19]. 
 bending (1375),-CN 








Fig. 3: IR spectra of Trigonella foenum-graecum polysaccharide (a), Rizatriptan benzoate (b) and Physical mixture (Rizatriptan benzoate 
and Trigonella foenum-graecum polysaccharide) (c) 
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The morphology of all the batches was examined by a Scanning 
Electron Microscopy (SEM) shown in fig. 4. Microspheres are 
spherical and possessed a smooth surface also they had no rupture 
on the surface; such morphology would result in slow clearance and 
good deposition pattern in a nasal cavity [16]. 
 
   
F1 F2 F3 
   
F4 F5 F6 
   
F7 F8 F9 
Fig. 4: SEM image all batches at 100× 
 
Result of in vitro drug release 
The release profiles of the drug from different batches of Trigonella 
foenum-graecum microspheres are shown in fig. 5. Batches of 
microspheres were found to release 50% drug within 15 min., and 
the whole drug content within 60 min. time except batch F7, which 
might due to high concentration of Trigonella foenum-graecum 
polysaccharide retarded the drug release from the microspheres, 
because of the viscous three-dimensional network at higher 
concentration of polysaccharide, which reduced the diffusion of 
drug. 
Result of release kinetics 
The release constant was calculated from the slope of the zero order, 
first order, Higuchi plots and determined the regression coefficient 
(R2) in the range of 0.70-0.98. It was found that the in vitro drug 
release of all the nine batches was best explained by zero order 
kinetic, as plot show the highest linearity, R2(see table 8), indicating 
diffusion controlled drug release. The corresponding plot log of 
cumulative percentage drug release vs. log time of the Korsmeyer-
Peppas equation indicated good linearity of regression coefficient 
(R2); 0.27-0.97. The release exponent (n) values for all the nine 
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batches were found to be>0.45, indicating that all batches followed 
the case II transport, which was the drug transport mechanism 
associated with stress in hydrophilic polysaccharides which swells 
in water and biological fluids. 
  
 
Fig. 5: In vitro release of microspheres. Each reading is an average of six determinants (mean+SD) (n=6) n= no. of observation 
 
Table 8: Model fitting of the release profile using four different models 
Formulations  Kinetic models(R2) 
Zero-order First order Higuchi Best fit model Korsmeyer peppa’s equation 
K value n value Mechanism 




F2 0.970 0.667 0.570 Zero order 0.9099 1.1713 
F3 0.701 0.995 0.977 Zero order 0.9713 1.1386 
F4 0.928 0.521 0.860 Zero order 0.2796 1.7691 
F5 0.956 0.985 0.893 Zero order 0.5426 1.4305 
F6 0.982 0.642 0.931 Zero order 0.6186 1.4152 
F7 0.962 0.802 0.916 Zero order 0.5138 1.3702 
F8 0.903 0.750 0.834 Zero order 0.2528 1.7623 
F9 0.916 0.558 0.85 Zero order 0.2728 1.7871 
 
Stability studies 
Stability studies for the optimized batch (F7) were carried out at a 
different temperature for 90 d. The formulation was evaluated for 
physical appearance and entrapment efficiency. There was no 
significant change in physical appearance and entrapment efficiency 
even after exposing to stress conditions at a different temperature. 
Hence, it was concluded that the F7 batch of microspheres has good 
stability during their shelf life. 
CONCLUSION 
The rizatriptan benzoate loaded polysaccharide based microspheres 
can be successfully prepared by double emulsion techniques. A full 
32 factorial design was applied taking drug polysaccharide ratio (X1) 
and stirring rate (X2
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